(Q33374055)

English

Phase II trial of irinotecan in children with relapsed or refractory rhabdomyosarcoma: a joint study of the French Society of Pediatric Oncology and the United Kingdom Children's Cancer Study Group

scientific article

Statements

Phase II trial of irinotecan in children with relapsed or refractory rhabdomyosarcoma: a joint study of the French Society of Pediatric Oncology and the United Kingdom Children's Cancer Study Group (English)
Gilles Vassal
Dominique Couanet
Elizabeth Stockdale
Daniel Orbach
Fabienne Pichon
Jean Claude Gentet
Christophe Bergeron
Laura Cisar
Sylvie Assadourian
French Society of Pediatric Oncology
United Kingdom Children's Cancer Study Group
1 February 2007

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit